KLP Kapitalforvaltning AS acquired a new position in Genpact Limited (NYSE:G - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 34,300 shares of the business services provider's stock, valued at approximately $1,473,000.
Several other institutional investors have also recently made changes to their positions in G. JPMorgan Chase & Co. increased its holdings in Genpact by 192.8% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,129,341 shares of the business services provider's stock valued at $122,701,000 after acquiring an additional 2,060,595 shares during the last quarter. Tandem Investment Advisors Inc. increased its holdings in shares of Genpact by 390.5% in the fourth quarter. Tandem Investment Advisors Inc. now owns 2,129,915 shares of the business services provider's stock worth $91,480,000 after purchasing an additional 1,695,706 shares during the last quarter. Victory Capital Management Inc. lifted its position in shares of Genpact by 18.1% in the fourth quarter. Victory Capital Management Inc. now owns 9,853,437 shares of the business services provider's stock worth $423,205,000 after buying an additional 1,511,790 shares in the last quarter. Geode Capital Management LLC boosted its stake in Genpact by 12.6% during the third quarter. Geode Capital Management LLC now owns 3,691,406 shares of the business services provider's stock valued at $148,142,000 after buying an additional 413,646 shares during the last quarter. Finally, Swiss National Bank purchased a new position in Genpact during the 4th quarter valued at approximately $14,298,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Genpact Trading Down 0.1 %
NYSE:G traded down $0.03 during mid-day trading on Wednesday, hitting $50.53. 1,561,085 shares of the stock traded hands, compared to its average volume of 1,350,328. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. Genpact Limited has a 52 week low of $30.23 and a 52 week high of $56.76. The stock has a market capitalization of $8.88 billion, a price-to-earnings ratio of 17.79, a PEG ratio of 1.84 and a beta of 1.06. The firm's 50 day moving average is $51.13 and its two-hundred day moving average is $45.31.
Genpact (NYSE:G - Get Free Report) last released its earnings results on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing analysts' consensus estimates of $0.86 by ($0.04). Genpact had a net margin of 10.77% and a return on equity of 22.50%. On average, equities research analysts predict that Genpact Limited will post 3.21 earnings per share for the current year.
Genpact Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th were given a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a dividend yield of 1.35%. This is an increase from Genpact's previous quarterly dividend of $0.15. The ex-dividend date was Tuesday, March 11th. Genpact's dividend payout ratio (DPR) is 23.94%.
Insider Transactions at Genpact
In other Genpact news, SVP Piyush Mehta sold 12,000 shares of the company's stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the sale, the senior vice president now directly owns 151,182 shares in the company, valued at approximately $6,475,125.06. This represents a 7.35 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the firm's stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the transaction, the chief executive officer now owns 310,246 shares in the company, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on G. Mizuho upped their price objective on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Jefferies Financial Group raised shares of Genpact from a "hold" rating to a "buy" rating and upped their price target for the company from $44.00 to $55.00 in a research note on Tuesday, January 21st. Needham & Company LLC lifted their price objective on shares of Genpact from $55.00 to $65.00 and gave the stock a "buy" rating in a research note on Friday, February 7th. Finally, TD Cowen upgraded shares of Genpact from a "hold" rating to a "buy" rating and upped their target price for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Six analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and an average price target of $48.44.
Check Out Our Latest Stock Analysis on Genpact
About Genpact
(
Free Report)
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
See Also

Before you consider Genpact, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.
While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report